| # | Title | Journal | Year | Citations |
|---|
| 1 | Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2015 | 74 |
| 2 | Accuracy and precision of smartphone applications and commercially available motion sensors in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2016 | 60 |
| 3 | Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 40 |
| 4 | Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 39 |
| 5 | Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 36 |
| 6 | Promotion of physical activity and exercise in multiple sclerosis: Importance of behavioral science and theory | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 36 |
| 7 | Epidemiology of neuromyelitis optica in Latin America | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 34 |
| 8 | Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2019 | 34 |
| 9 | COVID-19 vaccination willingness among people with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 | 34 |
| 10 | Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 32 |
| 11 | No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 32 |
| 12 | The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 31 |
| 13 | Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2019 | 29 |
| 14 | Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2019 | 29 |
| 15 | Association of multiple sclerosis and sudden sensorineural hearing loss | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2016 | 28 |
| 16 | Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 28 |
| 17 | A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 28 |
| 18 | Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 | 28 |
| 19 | Randomized controlled trial of an e-learning designed behavioral intervention for increasing physical activity behavior in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 27 |
| 20 | High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2020 | 27 |
| 21 | Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2015 | 26 |
| 22 | Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2015 | 26 |
| 23 | The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2015 | 26 |
| 24 | Experience with long-term rituximab use in a multiple sclerosis clinic | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2016 | 26 |
| 25 | MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 26 |
| 26 | Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging study | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 25 |
| 27 | A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 25 |
| 28 | Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2020 | 25 |
| 29 | Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2020 | 25 |
| 30 | Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2020 | 25 |
| 31 | Treadmill walking exercise training and brain function in multiple sclerosis: Preliminary evidence setting the stage for a network-based approach to rehabilitation | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 23 |
| 32 | Improved cognitive performance and event-related potential changes following working memory training in patients with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 23 |
| 33 | Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2019 | 23 |
| 34 | The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 22 |
| 35 | National estimates of self-reported sitting time in adults with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 22 |
| 36 | Remotely-delivered cognitive remediation in multiple sclerosis (MS): protocol and results from a pilot study | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2015 | 21 |
| 37 | Effects of a DVD-delivered exercise intervention on physical function in older adults with multiple sclerosis: A pilot randomized controlled trial | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2015 | 21 |
| 38 | Skeletal muscle mitochondrial capacity in people with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2016 | 21 |
| 39 | Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 21 |
| 40 | Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 20 |
| 41 | Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 20 |
| 42 | A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 20 |
| 43 | Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 20 |
| 44 | Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2017 | 20 |
| 45 | Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 | 20 |
| 46 | The relationship between fatigability and sleep quality in people with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2016 | 19 |
| 47 | Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 19 |
| 48 | Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 19 |
| 49 | Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 | 18 |
| 50 | The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2020 | 18 |
